Insiders Trades
KA
KAO Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest was filed 24 May 2026.
KAO: what insiders have been doing
KAO, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €20k, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €20k, the purchase published on 24 May 2026 is the largest of the period. Among those who bought: 1 senior executive.
Across the 2,530 companies tracked on its exchange, the median is 3 filings; at 2 filings, this issuer sits below that mark. Our records for KAO go back to 2026, with 1 purchase and no sales on the open market in total.
The last insider purchase was made public on 24 May 2026, 146 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€20,204
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleUnknown1 buy
Financial data
· cache
A$0.76
Analyst consensus
Valuation
P/Book377.5x
Profitability & ownership
% insiders41.7%
% institutions1.4%
Last declaration on 24 May 2026
About KAO
KAO is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
